Orexo AB (FRA:C5G)
€ 1.078 0.203 (23.2%) Market Cap: 37.46 Mil Enterprise Value: 78.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q2 2024 Orexo AB Earnings Call Transcript

Jul 17, 2024 / 12:00PM GMT
Release Date Price: €1.48 (-13.06%)
Nikolaj Sorensen
Orexo AB - President, Chief Executive Officer

Welcome to this half-year interim report for Orexo, a quarter and half year which has been a little of a mixed back with some good progress, but also some areas where we have been surprised by a negative -- recent negative development. So I think the headline of today is probably the complete response letter we received on OX124 on -- very late on Tuesday evening and also the press release we had yesterday.

I would just start to say that for Orexo that we would receive a complete response letter was not a surprise. We had expected that. We did talk about that in our last-quarter report that we would be delayed, and that was due to the human factor study and the instructions for use that needed to be updated.

However, there were some requests for technical data that came as a surprise, and that requires a little more work from our side. But I will come back to that.

But I think the really positive thing is that there's only one problem in the complete response letter with the product, and that was related to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot